Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
Autoimmune lymphoproliferative syndrome (ALPS) type Ia is caused by inherited defects in apoptosis and is characterized by nonmalignant lymphoaccumulation, autoimmunity, and increased alpha/beta(+) double-negative T cells (alpha/beta(+)-DNT cells). This study reports immunophenotypic findings in 166 members of 31 families with ALPS type Ia, associated with genetic mutations in the TNFRSF6 gene encoding Fas. The ALPS type Ia probands (n = 31) and relatives having both a Fas mutation and clinically proven ALPS (n = 28) showed significant expansion of CD8(+) T cells, alpha/beta(+)-DNT cells, gamma/delta(+)-DNT cells, CD3(+)/ HLA-DR(+) T cells, CD8(+)/CD57(+) T cells, and CD5(+) B cells. Relatives with Fas mutations, but without all the required criteria for ALPS (n = 42), had expansions of CD8(+) T cells, alpha/beta(+)-DNT cells, and gamma/delta(+)-DNT cells. Interestingly, relatives without a Fas mutation and with no features of ALPS (n = 65) demonstrated a small but significant expansion of CD8(+) T cells, both DNT cell subsets, and CD5(+) B cells. As compared to unrelated healthy controls, lymphocyte subset alterations were greatest in the probands, followed by the relatives with mutations and ALPS. Probands and relatives with mutations and ALPS also showed a lower number of CD4(+)/CD25(+) T cells that, in combination with an independent increase in HLA-DR(+) T cells, provided a profile predictive of the presence of clinical ALPS. Because quantitative defects in apoptosis were similar in mutation-positive relatives regardless of the presence of clinical ALPS, factors, other than modifiers of the Fas apoptosis pathway, leading to these distinctive immunophenotypic profiles most likely contribute to disease penetrance in ALPS.
Bleesing
J J
JJ
Immunology Service, Department of Laboratory Medicine, Clinical Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. blessingjacobh@uams.edu
Brown
M R
MR
Straus
S E
SE
Dale
J K
JK
Siegel
R M
RM
Johnson
M
M
Lenardo
M J
MJ
Puck
J M
JM
Fleisher
T A
TA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015703:Antigens, CD / Q000097:blood / Q000235:genetics / Q000276:immunology; D017209:Apoptosis; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry; D006684:HLA-DR Antigens / Q000235:genetics; D006801:Humans; D016130:Immunophenotyping / Q000379:methods; D016131:Lymphocyte Subsets / Q000276:immunology*; D008232:Lymphoproliferative Disorders / Q000097:blood / Q000235:genetics / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D044469:Racial Groups; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics; D013577:Syndrome; D013601:T-Lymphocytes / Q000276:immunology; D014481:United States; D019014:fas Receptor / Q000235:genetics
D015703:Antigens, CD; D006684:HLA-DR Antigens; D016693:Receptors, Antigen, T-Cell, alpha-beta; D019014:fas Receptor